Rap2b, a novel p53 target, regulates p53-mediated pro-survival function

References

• Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53. Cell 2009; 137:413 - 31; http://dx.doi.org/10.1016/j.cell.2009.04.037; PMID: 19410540
   PubMed Web of Science ®Google Scholar
• Kruse JP, Gu W. Modes of p53 regulation. Cell 2009; 137:609 - 22; http://dx.doi.org/10.1016/j.cell.2009.04.050; PMID: 19450511
   PubMed Web of Science ®Google Scholar
• Rozan LM, El-Deiry WS. p53 downstream target genes and tumor suppression: a classical view in evolution. Cell Death Differ 2007; 14:3 - 9; http://dx.doi.org/10.1038/sj.cdd.4402058; PMID: 17068503
   PubMed Web of Science ®Google Scholar
• Zhang X, Huang J. Integrative genome-wide approaches in embryonic stem cell research. Integr Biol (Camb) 2010; 2:510 - 6; http://dx.doi.org/10.1039/c0ib00068j; PMID: 20852801
   PubMed Web of Science ®Google Scholar
• Schlereth K, Charles JP, Bretz AC, Stiewe T. Life or death: p53-induced apoptosis requires DNA binding cooperativity. Cell Cycle 2010; 9:4068 - 76; http://dx.doi.org/10.4161/cc.9.20.13595; PMID: 20948308
   PubMed Web of Science ®Google Scholar
• Helton ES, Chen X. p53 modulation of the DNA damage response. J Cell Biochem 2007; 100:883 - 96; http://dx.doi.org/10.1002/jcb.21091; PMID: 17031865
   PubMed Web of Science ®Google Scholar
• Aylon Y, Oren M. Living with p53, dying of p53. Cell 2007; 130:597 - 600; http://dx.doi.org/10.1016/j.cell.2007.08.005; PMID: 17719538
   PubMed Web of Science ®Google Scholar
• Jänicke RU, Sohn D, Schulze-Osthoff K. The dark side of a tumor suppressor: anti-apoptotic p53. Cell Death Differ 2008; 15:959 - 76; http://dx.doi.org/10.1038/cdd.2008.33; PMID: 18356920
   PubMed Web of Science ®Google Scholar
• Tang Y, Luo J, Zhang W, Gu W. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell 2006; 24:827 - 39; http://dx.doi.org/10.1016/j.molcel.2006.11.021; PMID: 17189186
   PubMed Web of Science ®Google Scholar
• Sykes SM, Mellert HS, Holbert MA, Li K, Marmorstein R, Lane WS, et al. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell 2006; 24:841 - 51; http://dx.doi.org/10.1016/j.molcel.2006.11.026; PMID: 17189187
   PubMed Web of Science ®Google Scholar
• Das S, Raj L, Zhao B, Kimura Y, Bernstein A, Aaronson SA, et al. Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation. Cell 2007; 130:624 - 37; http://dx.doi.org/10.1016/j.cell.2007.06.013; PMID: 17719541
   PubMed Web of Science ®Google Scholar
• Tanaka T, Ohkubo S, Tatsuno I, Prives C. hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes. Cell 2007; 130:638 - 50; http://dx.doi.org/10.1016/j.cell.2007.08.001; PMID: 17719542
   PubMed Web of Science ®Google Scholar
• Wu WS, Heinrichs S, Xu D, Garrison SP, Zambetti GP, Adams JM, et al. Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 2005; 123:641 - 53; http://dx.doi.org/10.1016/j.cell.2005.09.029; PMID: 16286009
   PubMed Web of Science ®Google Scholar
• Caratozzolo MF, Micale L, Turturo MG, Cornacchia S, Fusco C, Marzano F, et al. TRIM8 modulates p53 activity to dictate cell cycle arrest. Cell Cycle 2012; 11:511 - 23; http://dx.doi.org/10.4161/cc.11.3.19008; PMID: 22262183
   PubMed Web of Science ®Google Scholar
• Xu Y, Chen X. Glyoxalase II, a detoxifying enzyme of glycolysis byproduct methylglyoxal and a target of p63 and p73, is a pro-survival factor of the p53 family. J Biol Chem 2006; 281:26702 - 13; http://dx.doi.org/10.1074/jbc.M604758200; PMID: 16831876
   PubMed Web of Science ®Google Scholar
• Leontieva OV, Gudkov AV, Blagosklonny MV. Weak p53 permits senescence during cell cycle arrest. Cell Cycle 2010; 9:4323 - 7; http://dx.doi.org/10.4161/cc.9.21.13584; PMID: 21051933
   PubMed Web of Science ®Google Scholar
• Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992; 358:80 - 3; http://dx.doi.org/10.1038/358080a0; PMID: 1614537
   PubMed Web of Science ®Google Scholar
• Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 1993; 53:2736 - 9; PMID: 8504413
   PubMed Web of Science ®Google Scholar
• Pei D, Zhang Y, Zheng J. Regulation of p53: a collaboration between Mdm2 and Mdmx. Oncotarget 2012; 3:228 - 35; PMID: 22410433
   PubMed Web of Science ®Google Scholar
• Viale A, De Franco F, Orleth A, Cambiaghi V, Giuliani V, Bossi D, et al. Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells. Nature 2009; 457:51 - 6; http://dx.doi.org/10.1038/nature07618; PMID: 19122635
   PubMed Web of Science ®Google Scholar
• Gasparini G, Longo R, Sarmiento R, Morabito A. Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?. Lancet Oncol 2003; 4:605 - 15; http://dx.doi.org/10.1016/S1470-2045(03)01220-8; PMID: 14554238
   PubMed Web of Science ®Google Scholar
• Vousden KH, Lu X. Live or let die: the cell’s response to p53. Nat Rev Cancer 2002; 2:594 - 604; http://dx.doi.org/10.1038/nrc864; PMID: 12154352
   PubMed Web of Science ®Google Scholar
• Li M, He Y, Feng X, Huang J. Genome-wide studies of the transcriptional regulation by p53. Biochim Biophys Acta 2012; 1819:684 - 7; http://dx.doi.org/10.1016/j.bbagrm.2012.02.002; PMID: 22348878
   PubMed Web of Science ®Google Scholar
• Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008; 9:402 - 12; http://dx.doi.org/10.1038/nrm2395; PMID: 18431400
   PubMed Web of Science ®Google Scholar
• Li M, He Y, Dubois W, Wu X, Shi J, Huang J. Distinct regulatory mechanisms and functions for p53-activated and p53-repressed DNA damage response genes in embryonic stem cells. Mol Cell 2012; 46:30 - 42; http://dx.doi.org/10.1016/j.molcel.2012.01.020; PMID: 22387025
   PubMed Web of Science ®Google Scholar
• Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, et al. A global map of p53 transcription-factor binding sites in the human genome. Cell 2006; 124:207 - 19; http://dx.doi.org/10.1016/j.cell.2005.10.043; PMID: 16413492
   PubMed Web of Science ®Google Scholar
• Smeenk L, van Heeringen SJ, Koeppel M, van Driel MA, Bartels SJ, Akkers RC, et al. Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Res 2008; 36:3639 - 54; http://dx.doi.org/10.1093/nar/gkn232; PMID: 18474530
   PubMed Web of Science ®Google Scholar
• Lee KH, Li M, Michalowski AM, Zhang X, Liao H, Chen L, et al. A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells. Proc Natl Acad Sci USA 2010; 107:69 - 74; http://dx.doi.org/10.1073/pnas.0909734107; PMID: 20018659
   PubMed Web of Science ®Google Scholar
• Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010; 142:409 - 19; http://dx.doi.org/10.1016/j.cell.2010.06.040; PMID: 20673990
   PubMed Web of Science ®Google Scholar
• Choi YJ, Lin CP, Ho JJ, He X, Okada N, Bu P, et al. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol 2011; 13:1353 - 60; http://dx.doi.org/10.1038/ncb2366; PMID: 22020437
   PubMed Web of Science ®Google Scholar
• Meshorer E, Yellajoshula D, George E, Scambler PJ, Brown DT, Misteli T. Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell 2006; 10:105 - 16; http://dx.doi.org/10.1016/j.devcel.2005.10.017; PMID: 16399082
   PubMed Web of Science ®Google Scholar
• Brosh R, Sarig R, Natan EB, Molchadsky A, Madar S, Bornstein C, et al. p53-dependent transcriptional regulation of EDA2R and its involvement in chemotherapy-induced hair loss. FEBS Lett 2010; 584:2473 - 7; http://dx.doi.org/10.1016/j.febslet.2010.04.058; PMID: 20434500
   PubMed Web of Science ®Google Scholar
• Rouault JP, Falette N, Guéhenneux F, Guillot C, Rimokh R, Wang Q, et al. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet 1996; 14:482 - 6; http://dx.doi.org/10.1038/ng1296-482; PMID: 8944033
   PubMed Web of Science ®Google Scholar
• Barak Y, Juven T, Haffner R, Oren M. mdm2 expression is induced by wild type p53 activity. EMBO J 1993; 12:461 - 8; PMID: 8440237
   PubMed Web of Science ®Google Scholar
• Yang G, Zhang G, Pittelkow MR, Ramoni M, Tsao H. Expression profiling of UVB response in melanocytes identifies a set of p53-target genes. J Invest Dermatol 2006; 126:2490 - 506; http://dx.doi.org/10.1038/sj.jid.5700470; PMID: 16888633
   PubMed Web of Science ®Google Scholar
• el-Deiry WS, Harper JW, O’Connor PM, Velculescu VE, Canman CE, Jackman J, et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994; 54:1169 - 74; PMID: 8118801
   PubMed Web of Science ®Google Scholar
• Wu GS, Burns TF, McDonald ER 3rd, Jiang W, Meng R, Krantz ID, et al. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet 1997; 17:141 - 3; http://dx.doi.org/10.1038/ng1097-141; PMID: 9326928
   PubMed Web of Science ®Google Scholar
• Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 2001; 7:683 - 94; http://dx.doi.org/10.1016/S1097-2765(01)00214-3; PMID: 11463392
   PubMed Web of Science ®Google Scholar
• Catalano A, Rodilossi S, Caprari P, Coppola V, Procopio A. 5-Lipoxygenase regulates senescence-like growth arrest by promoting ROS-dependent p53 activation. EMBO J 2005; 24:170 - 9; http://dx.doi.org/10.1038/sj.emboj.7600502; PMID: 15616590
   PubMed Web of Science ®Google Scholar
• Hong Y, Stambrook PJ. Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation. Proc Natl Acad Sci USA 2004; 101:14443 - 8; http://dx.doi.org/10.1073/pnas.0401346101; PMID: 15452351
   PubMed Web of Science ®Google Scholar
• Liu G, Chen X. Regulation of the p53 transcriptional activity. J Cell Biochem 2006; 97:448 - 58; http://dx.doi.org/10.1002/jcb.20700; PMID: 16288459
   PubMed Web of Science ®Google Scholar
• Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004; 303:844 - 8; http://dx.doi.org/10.1126/science.1092472; PMID: 14704432
   PubMed Web of Science ®Google Scholar
• el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. Definition of a consensus binding site for p53. Nat Genet 1992; 1:45 - 9; http://dx.doi.org/10.1038/ng0492-45; PMID: 1301998
   PubMed Web of Science ®Google Scholar
• Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT, et al. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 2004; 119:847 - 60; http://dx.doi.org/10.1016/j.cell.2004.11.004; PMID: 15607980
   PubMed Web of Science ®Google Scholar
• Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G, Murcia JM. Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 1998; 273:33533 - 9; http://dx.doi.org/10.1074/jbc.273.50.33533; PMID: 9837934
   PubMed Web of Science ®Google Scholar
• Han JA, Kim JI, Ongusaha PP, Hwang DH, Ballou LR, Mahale A, et al. P53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis. EMBO J 2002; 21:5635 - 44; http://dx.doi.org/10.1093/emboj/cdf591; PMID: 12411481
   PubMed Web of Science ®Google Scholar
• Koeppel M, van Heeringen SJ, Smeenk L, Navis AC, Janssen-Megens EM, Lohrum M. The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response. Nucleic Acids Res 2009; 37:322 - 35; http://dx.doi.org/10.1093/nar/gkn940; PMID: 19042971
   PubMed Web of Science ®Google Scholar
• Seoane J, Le HV, Massagué J. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 2002; 419:729 - 34; http://dx.doi.org/10.1038/nature01119; PMID: 12384701
   PubMed Web of Science ®Google Scholar
• Luo J, Emanuele MJ, Li D, Creighton CJ, Schlabach MR, Westbrook TF, et al. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 2009; 137:835 - 48; http://dx.doi.org/10.1016/j.cell.2009.05.006; PMID: 19490893
   PubMed Web of Science ®Google Scholar
• Laptenko O, Prives C. Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ 2006; 13:951 - 61; http://dx.doi.org/10.1038/sj.cdd.4401916; PMID: 16575405
   PubMed Web of Science ®Google Scholar
• Wilkinson DS, Tsai WW, Schumacher MA, Barton MC. Chromatin-bound p53 anchors activated Smads and the mSin3A corepressor to confer transforming-growth-factor-beta-mediated transcription repression. Mol Cell Biol 2008; 28:1988 - 98; http://dx.doi.org/10.1128/MCB.01442-07; PMID: 18212064
   PubMed Web of Science ®Google Scholar
• Murphy M, Ahn J, Walker KK, Hoffman WH, Evans RM, Levine AJ, et al. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev 1999; 13:2490 - 501; http://dx.doi.org/10.1101/gad.13.19.2490; PMID: 10521394
   PubMed Web of Science ®Google Scholar
• Tsai WW, Nguyen TT, Shi Y, Barton MC. p53-targeted LSD1 functions in repression of chromatin structure and transcription in vivo. Mol Cell Biol 2008; 28:5139 - 46; http://dx.doi.org/10.1128/MCB.00287-08; PMID: 18573881
   PubMed Web of Science ®Google Scholar
• Carvajal LA, Hamard PJ, Tonnessen C, Manfredi JJ. E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression. Genes Dev 2012; 26:1533 - 45; http://dx.doi.org/10.1101/gad.184911.111; PMID: 22802528
   PubMed Web of Science ®Google Scholar
• Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80:293 - 9; http://dx.doi.org/10.1016/0092-8674(95)90412-3; PMID: 7834749
   PubMed Web of Science ®Google Scholar
• Riccardi C, Nicoletti I. Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 2006; 1:1458 - 61; http://dx.doi.org/10.1038/nprot.2006.238; PMID: 17406435
   PubMed Web of Science ®Google Scholar